Immunotherapy and targeted-therapy combinations mark a new era of kidney cancer treatment.

Journal Article (Journal Article)

Full Text

Duke Authors

Cited Authors

  • Zhang, T; George, DJ

Published Date

  • April 2021

Published In

Volume / Issue

  • 27 / 4

Start / End Page

  • 586 - 588

PubMed ID

  • 33820997

Electronic International Standard Serial Number (EISSN)

  • 1546-170X

Digital Object Identifier (DOI)

  • 10.1038/s41591-021-01320-x

Language

  • eng

Conference Location

  • United States